Literature DB >> 28958037

Evaluation of changes in cartilage viability in detergent-treated tracheal grafts for immunosuppressant-free allotransplantation in dogs.

Tao Lu1, Yiwei Huang1, Yulei Qiao1, Yongxing Zhang1, Yu Liu1.   

Abstract

OBJECTIVES: The first tissue-engineered clinical tracheal transplant prepared using the detergent-enzymatic method resulted in graft stenosis, possibly from detergent-enzymatic method-induced graft non-viability. We reported on the transplantation of de-epithelialized tracheal allografts while maintaining cartilage viability in dogs. No lethal stenosis occurred in allografts. Herein, on the basis of previous experimentation, we assessed cartilage viability in detergent-treated cartilages.
METHODS: Six canine tracheal grafts were treated with detergent [1% t-octylphenoxypolyethoxyethanol (Triton X-100)] before transplantation. The histoarchitecture was evaluated, and the viable chondrocytes ratio was calculated. Glycosaminoglycan was detected using safranin-O staining. Collagen II was tested using immunohistochemistry.
RESULTS: The epithelium was completely removed in 5 grafts. Compared with fresh tracheas, the viable chondrocyte ratio was significantly reduced in the de-epithelialized grafts (100 vs 54.70 ± 8.56%; P < 0.001). Image analysis revealed that the mean optical density of glycosaminoglycan (0.363 ± 0.027 vs 0.307 ± 0.012; P = 0.007) and collagen II (0.115 ± 0.013 vs 0.092 ± 0.011; P = 0.028) was decreased. The observation period ranged from 91 to 792 days. No stenosis occurred in 5 allografts; moderate stenosis developed in 1 allograft during the 4th week after surgery. The chondrocyte nuclei almost completely disappeared. Both glycosaminoglycan (0.307 ± 0.012 vs 0.164 ± 0.104; P = 0.044) and collagen II (0.092 ± 0.011 vs 0.068 ± 0.022; P = 0.022) were significantly degraded.
CONCLUSIONS: This study demonstrated successful tracheal transplantation; about 50% of the viable chondrocytes were retained in the cartilage that could prevent development of a lethal stenosis in tracheal grafts.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28958037     DOI: 10.1093/ejcts/ezx317

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

Review 1.  Tissue engineering applications in otolaryngology-The state of translation.

Authors:  Weston L Niermeyer; Cole Rodman; Michael M Li; Tendy Chiang
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-06-19

2.  Computational fluid dynamics for enhanced tracheal bioreactor design and long-segment graft recellularization.

Authors:  Hankyu Lee; Alba E Marin-Araujo; Fabio G Aoki; Siba Haykal; Thomas K Waddell; Cristina H Amon; David A Romero; Golnaz Karoubi
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

3.  Regeneration of partially decellularized tracheal scaffolds in a mouse model of orthotopic tracheal replacement.

Authors:  Lumei Liu; Sayali Dharmadhikari; Kimberly M Shontz; Zheng Hong Tan; Barak M Spector; Brooke Stephens; Maxwell Bergman; Amy Manning; Kai Zhao; Susan D Reynolds; Christopher K Breuer; Tendy Chiang
Journal:  J Tissue Eng       Date:  2021-06-06       Impact factor: 7.940

4.  A Novel Bioreactor for Reconstitution of the Epithelium and Submucosal Glands in Decellularized Ferret Tracheas.

Authors:  Albert C Pai; Thomas J Lynch; Bethany A Ahlers; Vitaly Ievlev; John F Engelhardt; Kalpaj R Parekh
Journal:  Cells       Date:  2022-03-18       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.